Breast cancer risk associated with hormone replacement therapy has been underestimated
Risk of breast cancer in women taking combined menopausal hormone therapy is three times higher than in non-users, study finds.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Men | Menopause | Study | Women